Cargando…

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach

Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung cancer. The range of KRAS point mutations observed in NSCLC necessitates a multiplex approach to efficient mutation detection in circulating DNA. Here we report the design and optimisation of three disc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pender, Alexandra, Garcia-Murillas, Isaac, Rana, Sareena, Cutts, Rosalind J., Kelly, Gavin, Fenwick, Kerry, Kozarewa, Iwanka, Gonzalez de Castro, David, Bhosle, Jaishree, O’Brien, Mary, Turner, Nicholas C., Popat, Sanjay, Downward, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586384/ https://www.ncbi.nlm.nih.gov/pubmed/26413866 http://dx.doi.org/10.1371/journal.pone.0139074

Ejemplares similares

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments
por: Minchom, Anna, et al.
Publicado: (2017)

Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)
por: Lee, Jen Y., et al.
Publicado: (2020)

Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
por: Lote, Hazel, et al.
Publicado: (2014)

Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond
por: Joshi, Kroopa, et al.
Publicado: (2021)

A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma
por: Minchom, Anna, et al.
Publicado: (2019)

Comprehensive Genomic Analysis of a BRCA2 Deficient Human Pancreatic Cancer
por: Barber, Louise J., et al.
Publicado: (2011)

Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress
por: McDade, Simon S., et al.
Publicado: (2014)

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial
por: Hrebien, S, et al.
Publicado: (2019)

Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of GC-biased genomes
por: Kozarewa, Iwanka, et al.
Publicado: (2009)

A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA
por: Kozarewa, Iwanka, et al.
Publicado: (2012)

A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity
por: Pettitt, Stephen J., et al.
Publicado: (2013)

A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice
por: Linch, Mark, et al.
Publicado: (2014)

Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience
por: Cui, Wanyuan, et al.
Publicado: (2020)

Whole Genome Sequencing Highlights Genetic Changes Associated with Laboratory Domestication of C. elegans
por: Weber, Katherine P., et al.
Publicado: (2010)

Correction: A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA
por: Kozarewa, Iwanka, et al.
Publicado: (2012)

Therapeutic KRAS(G12C) inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers
por: Mugarza, Edurne, et al.
Publicado: (2022)

Disruption of the Interaction of RAS with PI 3-Kinase Induces Regression of EGFR-Mutant-Driven Lung Cancer
por: Murillo, Miguel M., et al.
Publicado: (2018)

Combined targeting of G protein‐coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN‐null triple negative breast cancer
por: Zecchin, Davide, et al.
Publicado: (2020)

Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice
por: Abdelraouf, Fatma, et al.
Publicado: (2015)

Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation
por: McDade, Simon S., et al.
Publicado: (2012)

Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer
por: Lalondrelle, Susan, et al.
Publicado: (2023)

HER3 expression and MEK activation in non-small-cell lung carcinoma
por: Manickavasagar, Thubeena, et al.
Publicado: (2021)

High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing
por: Sims, David, et al.
Publicado: (2011)

High-throughput multiplexed fluorescence-activated droplet sorting
por: Caen, Ouriel, et al.
Publicado: (2018)

Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
por: Vaclova, Tereza, et al.
Publicado: (2022)

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
por: Ha, Kevin CH, et al.
Publicado: (2011)

Determination of HER2 Amplification Status on Tumour DNA by Digital PCR
por: Garcia-Murillas, Isaac, et al.
Publicado: (2013)

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations
por: Kingston, Belinda, et al.
Publicado: (2019)

1748P Real-world outcomes in thoracic cancer patients (pts) with severe acute respiratory syndrome coronavirus 2 (COVID-19): Single UK institution experience
por: Cui, W., et al.
Publicado: (2020)

Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma
por: Lee, Jen Y, et al.
Publicado: (2017)

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer
por: O’Leary, Ben, et al.
Publicado: (2020)

Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR
por: Olmedillas-López, Susana, et al.
Publicado: (2017)

Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C
por: Dryden, Nicola H., et al.
Publicado: (2014)

Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications
por: Hindocha, Sumeet, et al.
Publicado: (2021)

HIV reservoir quantification by five-target multiplex droplet digital PCR
por: Levy, Claire N., et al.
Publicado: (2021)

Lossless enrichment of trace analytes in levitating droplets for multiphase and multiplex detection
por: Chen, Xueyan, et al.
Publicado: (2022)

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells
por: Pettitt, Stephen J., et al.
Publicado: (2017)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
por: Demuth, Christina, et al.
Publicado: (2018)

Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies
por: Steckel, Michael, et al.
Publicado: (2012)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vius1ottu12s7kbo7ngvq70mdk